Fingerprint
Dive into the research topics of 'Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: A phase III, randomized, open-label trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically